Exploring Biomarkers to Predict the Response to Immunotherapy-Based Combination Treatment in Hepatocellular Carcinoma Using Epiontis ID™ Reza Sedaghat2022-10-06T10:33:50-04:00Resources| Read More
Effects on CD3, Treg, and TH17 Cell Numbers in Skin Biopsies After 16-Week Mirikizumab Treatment, Evaluated by an Epigenetic Assay Carlos Bonilla2022-08-08T17:01:14-04:00Resources| Read More
Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci Carlos Bonilla2022-08-08T17:06:12-04:00Resources| Read More
Biological Impact of Iberdomide in Patients With Active Systemic Lupus Erythematosus Carlos Bonilla2022-08-19T16:19:48-04:00Resources| Read More
Regulatory T-Cells and Associated Pathways in Metastatic Renal Cell Carcinoma (mRCC) Patients Undergoing DC-Vaccination and Cytokine-Therapy Carlos Bonilla2022-08-08T17:11:33-04:00Resources| Read More
